Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: A longitudinal study in a large Japanese population

American Journal of Kidney Diseases

Volumn 66, Issue 6, 2015, Pages 972-983

  Tsuruya, Kazuhiko ^a,b   Yoshida, Hisako ^a   Nagata, Masaharu ^a   Kitazono, Takanari ^a   Iseki, Kunitoshi ^b   Iseki, Chiho ^c   Fujimoto, Shouichi ^b   Konta, Tsuneo ^b   Moriyama, Toshiki ^b   Yamagata, Kunihiro ^b   Narita, Ichiei ^b   Kimura, Kenjiro ^b   Kondo, Masahide ^b   Asahi, Koichi ^b   Kurahashi, Issei ^d   Ohashi, Yasuo ^e   Watanabe, Tsuyoshi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b Steering Committee for Design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by Specific Health Checkups   (Japan)

^c UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^d IAnalysis LLC   (Japan)

^e CHUO UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease (CKD); diabetes; dyslipidemia; estimated glomerular filtration rate (eGFR); Japanese population; kidney disease progression; lipid nephrotoxicity; proteinuria; triglycerides to high density lipoprotein cholesterol ratio; urinary protein excretion

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; INCIDENCE; JAPANESE (PEOPLE); LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC RATIO; POPULATION; PREVALENCE; PROTEIN URINE LEVEL; RISK ASSESSMENT; RISK FACTOR; URINARY EXCRETION; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; ETHNOLOGY; HEALTH SURVEY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TRIGLYCERIDES;

EID: 84941043796     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.05.011     Document Type: Article

References (36)

1. E. Ritz, and C. Wanner Lipid changes and statins in chronic renal insufficiency J Am Soc Nephrol 17 12 suppl 3 2006 S226 S230
2. N.D. Vaziri Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences Am J Physiol Renal Physiol 290 2 2006 F262 F272
3. J. Jeppesen, H.O. Hein, P. Suadicani, and F. Gyntelberg Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study Arterioscler Thromb Vasc Biol 17 6 1997 1114 1120
4. S.J. Robins, A. Lyass, J.P. Zachariah, J.M. Massaro, and R.S. Vasan Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study Arterioscler Thromb Vasc Biol 31 5 2011 1208 1214
5. C. Giannini, N. Santoro, S. Caprio, and et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds Diabetes Care 34 8 2011 1869 1874
6. D. Gasevic, J. Frohlich, G.B. Mancini, and S.A. Lear The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort Metabolism 61 4 2012 583 589
7. T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, and G. Reaven Use of metabolic markers to identify overweight individuals who are insulin resistant Ann Intern Med 139 10 2003 802 809
8. M.R. Salazar, H.A. Carbajal, W.G. Espeche, and et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women Am J Cardiol 109 12 2012 1749 1753
9. C. Maruyama, K. Imamura, and T. Teramoto Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia J Atheroscler Thromb 10 3 2003 186 191
10. N.C. Bhalodkar, S. Blum, and E.A. Enas Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians Am J Cardiol 97 7 2006 1007 1009
11. R. Boizel, P.Y. Benhamou, B. Lardy, F. Laporte, T. Foulon, and S. Halimi Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels Diabetes Care 23 11 2000 1679 1685
12. J.M. Gaziano, C.H. Hennekens, C.J. O'Donnell, J.L. Breslow, and J.E. Buring Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction Circulation 96 8 1997 2520 2525
13. F. Barzi, A. Patel, M. Woodward, and et al. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region Ann Epidemiol 15 5 2005 405 413
14. V. Bittner, B.D. Johnson, I. Zineh, and et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Am Heart J 157 3 2009 548 555
15. K. Tsuruya, H. Yoshida, M. Nagata, and et al. Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population Atherosclerosis 233 1 2014 260 267
16. S. Matsuo, E. Imai, M. Horio, and et al. Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 6 2009 982 992
17. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 suppl 1 2010 S62 S69
18. A. Levin, and P.E. Stevens Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward Kidney Int 85 1 2014 49 61
19. J. Coresh, T.C. Turin, K. Matsushita, and et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality JAMA 311 24 2014 2518 2531
20. P. Muntner, J. Coresh, J.C. Smith, J. Eckfeldt, and M.J. Klag Plasma lipids and risk of developing renal dysfunction: the Atherosclerosis Risk in Communities Study Kidney Int 58 1 2000 293 301
21. E.S. Schaeffner, T. Kurth, G.C. Curhan, and et al. Cholesterol and the risk of renal dysfunction in apparently healthy men J Am Soc Nephrol 14 8 2003 2084 2091
22. C.S. Fox, M.G. Larson, E.P. Leip, B. Culleton, P.W. Wilson, and D. Levy Predictors of new-onset kidney disease in a community-based population JAMA 291 7 2004 844 850
23. H.T. Kang, J.K. Kim, J.Y. Kim, J.A. Linton, J.H. Yoon, and S.B. Koh Independent association of TG/HDL-C with urinary albumin excretion in normotensive subjects in a rural Korean population Clin Chim Acta 413 1-2 2012 319 324
24. H.T. Kang, J.Y. Shim, Y.J. Lee, and et al. Association between the ratio of triglycerides to high-density lipoprotein cholesterol and chronic kidney disease in Korean adults: the 2005 Korean National Health and Nutrition Examination Survey Kidney Blood Press Res 34 3 2011 173 179
25. J.Y. Kim, H.T. Kang, H.R. Lee, Y.J. Lee, and J.Y. Shim Comparison of lipid-related ratios for prediction of chronic kidney disease stage 3 or more in Korean adults J Korean Med Sci 27 12 2012 1524 1529
26. G. Zoppini, C. Negri, V. Stoico, S. Casati, I. Pichiri, and E. Bonora Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus Metabolism 61 1 2012 22 29
27. D.P. Mikhailidis, M. Elisaf, M. Rizzo, and et al. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses Curr Vasc Pharmacol 9 5 2011 533 571
28. J.F. Moorhead, M.K. Chan, M. El-Nahas, and Z. Varghese Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease Lancet 2 8311 1982 1309 1311
29. X.Z. Ruan, Z. Varghese, and J.F. Moorhead An update on the lipid nephrotoxicity hypothesis Nat Rev Nephrol 5 12 2009 713 721
30. N.D. Vaziri Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease Clin Exp Nephrol 18 2 2014 265 268
31. C.K. Glass, and J.L. Witztum Atherosclerosis. the road ahead Cell 104 4 2001 503 516
32. N. Tolonen, C. Forsblom, L. Thorn, and et al. Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes Diabetologia 52 12 2009 2522 2530
33. M.C. Thomas, M. Rosengard-Barlund, V. Mills, and et al. Serum lipids and the progression of nephropathy in type 1 diabetes Diabetes Care 29 2 2006 317 322
34. E. Streja, C.P. Kovesdy, D.A. Streja, H. Moradi, K. Kalantar-Zadeh, and M.L. Kashyap Niacin and progression of CKD Am J Kidney Dis 65 5 2015 785 798
35. V. Krane, and C. Wanner The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease Nephrol Dial Transplant 17 suppl 11 2002 23 27
36. T. Usui, T. Ninomiya, M. Nagata, and et al. Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study Circ J 77 9 2013 2311 2317